BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34602315)

  • 1. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients.
    Beumer BR; Buettner S; Galjart B; van Vugt JLA; de Man RA; IJzermans JNM; Koerkamp BG
    Eur J Surg Oncol; 2022 Mar; 48(3):492-499. PubMed ID: 34602315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
    Farinati F; Vitale A; Spolverato G; Pawlik TM; Huo TL; Lee YH; Frigo AC; Giacomin A; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Biasini E; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Masotto A; Trevisani F; Cillo U;
    PLoS Med; 2016 Apr; 13(4):e1002006. PubMed ID: 27116206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.
    Kitai S; Kudo M; Izumi N; Kaneko S; Ku Y; Kokudo N; Sakamoto M; Takayama T; Nakashima O; Kadoya M; Matsuyama Y; Matsunaga T
    Dig Dis; 2014; 32(6):717-24. PubMed ID: 25376289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
    Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
    PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
    Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
    Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
    Kudo M; Chung H; Osaki Y
    J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
    Gomaa AI; Hashim MS; Waked I
    PLoS One; 2014; 9(3):e90929. PubMed ID: 24603710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
    Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
    J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating baseline MR imaging biomarkers into BCLC and CLIP improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
    Aliyari Ghasabeh M; Shaghaghi M; Pandey A; Ameli S; Ambale Venkatesh B; Jacob A; Pandey P; Hazhirkarzar B; Luo Y; Rezvani Habibabadi R; Khoshpouri P; Ghadimi M; Kamel IR
    Eur Radiol; 2021 Mar; 31(3):1630-1641. PubMed ID: 32910233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
    Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
    BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.
    Shao YY; Lu LC; Lin ZZ; Hsu C; Shen YC; Hsu CH; Cheng AL
    Br J Cancer; 2012 Nov; 107(10):1672-7. PubMed ID: 23059748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.
    Nishikawa H; Kita R; Kimura T; Endo M; Ohara Y; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
    Int J Oncol; 2015; 46(6):2371-9. PubMed ID: 25891119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study.
    Su L; Zhou T; Zhang Z; Zhang X; Zhi X; Li C; Wang Q; Jia C; Shi W; Yue Y; Gao Y; Cheng B
    BMC Cancer; 2016 Jul; 16():424. PubMed ID: 27387757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
    Chun YH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Kim BK; Choi GH; Kim KS; Choi JS; Ahn SH
    Eur J Cancer; 2011 Nov; 47(17):2568-75. PubMed ID: 21835608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.